Plain-English translation of NCT07010198 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing five different strategies to screen for liver cancer in people who carry hepatitis B. Researchers want to see which combination of blood tests and ultrasound works best at catching liver cancer early, when it's easier to treat. The study will follow about 4,500 people over time to compare how well each screening method works.
Liver cancer is a serious disease, but catching it early can save lives. This study exists because doctors aren't sure which screening method works best for people with hepatitis B, so researchers want to compare different approaches head-to-head to find the most effective one.
You likely qualify if…
You likely don't qualify if…
You would have blood tests and ultrasound scans of your liver every six months for the duration of the study. The researchers will also use information from your medical history and these regular tests to see how well five different screening methods predict your risk of developing liver cancer. Your participation helps doctors understand which screening approach works best for people with hepatitis B.
AI-generated summary from trial data · Jul 2, 2026 · Not medical advice
China